The purpose of this study is to evaluate the safety and effect of CK-2127107 on respiratory function (SVC) and muscle function in ALS.
Contact site for start date.
Please contact ClinicalResearch@sutterhealth.org about Study NCT 03160898.
Subjects with amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig's disease who are aged 80 years or less, have good breathing (FVC greater than 65%) and who have been diagnosed for less than 24 months.
June 01, 2018